Results 271 to 280 of about 112,073 (304)
Some of the next articles are maybe not open access.
Non-alcoholic fatty liver disease
British Journal of Hospital Medicine, 2005This article reviews the nomenclature, clinical and histological basis for a diagnosis of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis, its natural history, pathophysiology and an approach to clinical management.
Ian Homer Y, Cua, Jacob, George
openaire +2 more sources
Non-alcoholic fatty liver disease in pregnancy
Obstetric Medicine, 2021Non-alcoholic fatty liver disease (NAFLD) is now the commonest liver pathology in the UK; however, relatively little is known about its course in pregnancy or the effect it has on maternal or fetal outcomes. Described here is a 24-year-old woman in her first pregnancy who presented with non-specific symptoms and raised alanine aminotransferase with ...
Charlotte S Benson +2 more
openaire +2 more sources
Non-alcoholic fatty liver disease
Critical Reviews in Clinical Laboratory Sciences, 2011Non-alcoholic fatty liver disease (NAFLD) refers to the accumulation of hepatic steatosis not due to excess alcohol consumption. The prevalence of NAFLD is up to 30% in developed countries and nearly 10% in developing nations, making NAFLD the most common liver condition in the world. The pathogenesis of NAFLD is related to insulin resistance and, thus,
Briohny W, Smith, Leon A, Adams
openaire +2 more sources
Epidemiology of Non-Alcoholic Fatty Liver Disease
Digestive Diseases, 2010Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20–30%. About 2–3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. As a rule, the
Bellentani S. +3 more
openaire +2 more sources
Liver transplantation for non-alcoholic fatty liver disease
Minerva Gastroenterology, 2018Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome, and it is defined by the presence of steatosis in >5% of hepatocytes, according to histological analysis or detected by specific proton density fat fraction obtained magnetic resonance imaging.
Giacomo, Germani, Chiara, Becchetti
openaire +2 more sources
Non-alcoholic fatty liver disease
Nursing Standard, 2016Essential facts Non-alcoholic fatty liver disease (NAFLD) is an excess of fat in the liver that is not the result of excessive alcohol consumption or other secondary causes, such as hepatitis C. According to the National Institute for Health and Care Excellence, fatty liver - steatosis - affects between 20% and 30% of the population and its prevalence ...
openaire +2 more sources
Non-alcoholic fatty liver disease and steatohepatitis
Orvosi Hetilap, 2013Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, the hepatic manifestations of metabolic syndrome with close association with inzulin resistance and obesity, are the most common liver diseases, affecting up to a third of the population worldwide.
Gabriella, Pár +2 more
openaire +2 more sources
Non‐alcoholic fatty liver disease: An overview
Journal of Gastroenterology and Hepatology, 2002AbstractNon‐alcoholic fatty liver disease (NAFL) includes a spectrum of clinicopathological conditions with increasing prevalence in the developed world. Although steatosis alone seems to have a benign course, those patients with the diagnosis of non‐alcoholic steatohepatitis (NASH) can have a progressive course.
Brian P, Mulhall +2 more
openaire +2 more sources
Pediatric Non-alcoholic Fatty Liver Disease
Current Gastroenterology Reports, 2016Childhood obesity has reached epidemic proportions, and by 2012, more than one third of American children were overweight or obese. As a result, increasingly, children are developing complications of obesity including liver disease. In fact, non-alcoholic fatty liver disease is the most common form of chronic liver disease seen in children today ...
Vikas, Uppal +2 more
openaire +2 more sources
Atherosclerosis and Non-Alcoholic Fatty Liver Disease
Angiology, 2022Non-alcoholic fatty liver disease (NAFLD) is a common disease defined by excess fat deposition in the liver. The course of NAFLD is not fully understood, however, some pathogenic mechanisms have been identified. Accumulation of fat in liver cells is associated with insulin resistance, central obesity, triglyceride accumulation in the liver and hepatic ...
openaire +2 more sources